- Home
- PSTL vs DRTS Comparison
PSTL vs DRTS Comparison
Compare PSTL & DRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PSTL
- DRTS
- Stock Information
- Founded
- PSTL 2018
- DRTS 2015
- Country
- PSTL United States
- DRTS Israel
- Employees
- PSTL N/A
- DRTS N/A
- Industry
- PSTL Real Estate Investment Trusts
- DRTS Medical/Dental Instruments
- Sector
- PSTL Real Estate
- DRTS Health Care
- Exchange
- PSTL Nasdaq
- DRTS Nasdaq
- Market Cap
- PSTL 329.8M
- DRTS 274.0M
- IPO Year
- PSTL 2019
- DRTS N/A
- Fundamental
- Price
- PSTL $14.47
- DRTS $3.02
- Analyst Decision
- PSTL Strong Buy
- DRTS Strong Buy
- Analyst Count
- PSTL 1
- DRTS 2
- Target Price
- PSTL $16.50
- DRTS $8.00
- AVG Volume (30 Days)
- PSTL 159.0K
- DRTS 43.3K
- Earning Date
- PSTL 08-05-2025
- DRTS 08-13-2025
- Dividend Yield
- PSTL 6.67%
- DRTS N/A
- EPS Growth
- PSTL 176.54
- DRTS N/A
- EPS
- PSTL 0.28
- DRTS N/A
- Revenue
- PSTL $81,235,000.00
- DRTS N/A
- Revenue This Year
- PSTL $19.86
- DRTS N/A
- Revenue Next Year
- PSTL $10.14
- DRTS N/A
- P/E Ratio
- PSTL $51.42
- DRTS N/A
- Revenue Growth
- PSTL 23.36
- DRTS N/A
- 52 Week Low
- PSTL $12.26
- DRTS $1.93
- 52 Week High
- PSTL $15.42
- DRTS $4.39
- Technical
- Relative Strength Index (RSI)
- PSTL 44.39
- DRTS 47.26
- Support Level
- PSTL $14.42
- DRTS $2.95
- Resistance Level
- PSTL $14.85
- DRTS $3.15
- Average True Range (ATR)
- PSTL 0.25
- DRTS 0.14
- MACD
- PSTL -0.07
- DRTS -0.02
- Stochastic Oscillator
- PSTL 7.14
- DRTS 17.50
About PSTL Postal Realty Trust Inc.
Postal Realty Trust Inc is an internally managed real estate corporation that owns and manages properties leased to the United States Postal Service, or the USPS. Its objective is to create stockholder value by generating risk-adjusted returns through expanding its portfolio of owned and managed postal properties leased to the USPS. The majority of the revenue is generated from the rental income received.
About DRTS Alpha Tau Medical Ltd.
Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company derives maximum revenue from Israel.